Vtex
NYSE:VTEXSoftware - Application
-$0.02 today
- Market cap
- $588.03M
- Beta
- 1.04
- P/E (TTM)
- 26.2
- EPS (TTM)
- $0.14
Volume 1.00M
Average 1.33M
VTEX Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
VtexNYSE: VTEX
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables grows, but more slowly than its trailing trend
Q1 FY2026 accounts receivables of $13.96M rose 91.9% year over year, behind the +149.3% change in trailing-twelve-month accounts receivables.
Context
- Accounts receivables amounted to 0.2% of revenue in FY2025, down 11.4 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +91.9% toward the trailing-twelve-month pace of +149.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 446K USD
- Year-over-year change
- +101.7%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 446K | +101.7% |
| FY2024 | 2024-12-31 | (26.17M) | -99.2% |
| FY2023 | 2023-12-31 | (13.14M) | -267.1% |
| FY2022 | 2022-12-31 | (3.58M) | +78.6% |
| FY2021 | 2021-12-31 | (16.75M) | — |
Accounts Receivables vs competitors
How VTEX compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +149.3% is the 5th highest of 9, against a peer median of +104.3%.
- Accounts receivables amounts to 3.3% of revenue for VTEX, versus a peer median of 2.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $70.19M USD | +396.3% | +43.8% | 12.4% | |
| LTM Mar 2026 | $20.79M USD | +1808.4% | — | 6.1% | |
| LTM Mar 2026 | $8.16M USD | +149.3% | — | 3.3% | |
| LTM Mar 2026 | $7.21M USD | -188.8% | -22.3% | 5.6% | |
| LTM Mar 2026 | $4.63M USD | -213.3% | -22.3% | 2.1% | |
| LTM Mar 2026 | $3.53M USD | +161.1% | -3.6% | 1.4% | |
| LTM Mar 2026 | $3.5M USD | -433.4% | -7.4% | 1.0% | |
| LTM Mar 2026 | $3.11M USD | +47.5% | +19.8% | 3.3% | |
| LTM Mar 2026 | $1.45M USD | +216.9% | — | 0.2% | |
| LTM Jun 2026 | CN¥0 CNY | — | — | 0.0% | |
| Peer median (excluding VTEX) | — | +104.3% | -5.5% | 2.1% | |
Competitors are the stored peer set for VTEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (60.51M) | (52.42M) | (13.69M) | 12M | 20.01M |
| Depreciation & Amortization | 4.07M | 4.62M | 5.02M | 4.36M | 3.26M |
| Deferred Income Tax | (3.51M) | (6.03M) | 1.25M | (2.33M) | 0 |
| Stock-Based Compensation | 9.22M | 12.2M | 19.69M | 15.55M | 0 |
| Change in Working Capital | 489K | 4.75M | 326K | (1.68M) | 1.89M |
| Accounts Receivables | (16.75M) | (3.58M) | (13.14M) | (26.17M) | 446K |
| Inventory | (2.51M) | 0 | 5.66M | 0 | 0 |
| Accounts Payables | 7.42M | 5.23M | 855K | (227K) | 0 |
| Other Working Capital | 12.33M | 3.1M | 6.95M | 24.72M | 1.44M |
| Other Non-Cash Items | (2.75M) | 7.66M | (8.34M) | (651K) | 8.2M |
| Operating Cash Flow | (52.99M) | (29.22M) | 4.26M | 27.26M | 33.37M |
| Capital Expenditures | (1.75M) | (340K) | (472K) | (2.07M) | (1.04M) |
| Acquisitions (Net) | (5.71M) | (1.69M) | 0 | (1.89M) | (3.69M) |
| Purchases of Investments | (177.82M) | (120.62M) | (135.55M) | (137.66M) | 0 |
| Sales of Investments | 17.91M | 78.01M | 171.2M | 120.92M | 0 |
| Other Investing Activities | 588K | 1.26M | 3.24M | 691K | 29.53M |
| Investing Cash Flow | (166.78M) | (43.38M) | 38.43M | (20.01M) | 24.8M |
| Debt Repayment | (11.8M) | (3.91M) | (2.81M) | (1.69M) | (47K) |
| Common Stock Issued | 297.32M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.42M) | (12.8M) | (35.24M) | (11.2M) | (59.11M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 587K | (2.87M) | (375K) | (1.15M) | (2.43M) |
| Financing Cash Flow | 283.68M | (19.58M) | (38.43M) | (14.03M) | (61.59M) |
| Effect of Forex Changes | (1.46M) | (4.43M) | (613K) | (2.57M) | 490K |
| Net Change in Cash | 62.45M | (96.61M) | 3.64M | (9.36M) | (2.93M) |
| Free Cash Flow | (54.74M) | (29.56M) | 3.79M | 25.19M | 32.33M |
Vtex
NYSE:VTEX
Intrinsic Alpha fair value
Locked
Current Price
$3.61
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.